能量多普勒超声与新型微血管多普勒超声技术(AngioPLUS)鉴别乳腺良恶性肿块的诊断性能比较
本研究纳入124个经病理证实的乳腺肿块(良性80个,占64.5%;恶性44个,占35.5%),比较能量多普勒超声与AngioPLUS鉴别乳腺良恶性肿块的诊断性能。采用受试者工作特征曲线分析计算并比较两种工具的鉴别能力,曲线下面积显示AngioPLUS优于能量多普勒超声,但差异无统计学意义。
要点
- AngioPLUS鉴别乳腺良恶性肿块的AUC优于能量多普勒超声,但差异无统计学意义。
- 研究纳入124个病理证实乳腺肿块,其中良性80个(64.5%)、恶性44个(35.5%)。
- 两种技术均用于乳腺肿块良恶性鉴别,诊断性能通过ROC曲线分析比较。
核心结论
- AngioPLUS鉴别乳腺良恶性肿块的曲线下面积优于能量多普勒超声,但差异无统计学意义。
研究设计与样本
- 研究论文,纳入124个经病理证实的乳腺肿块(良性80个,占64.5%;恶性44个,占35.5%),比较能量多普勒超声与AngioPLUS的诊断性能,采用受试者工作特征曲线分析计算并比较。
诊断标准与关键数值
- 采用受试者工作特征曲线分析计算并比较能量多普勒超声与AngioPLUS鉴别乳腺良恶性肿块的诊断性能。
- 曲线下面积显示AngioPLUS优于能量多普勒超声,但差异无统计学意义。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
This study was performed to compare the diagnostic performance of power Doppler ultrasound (US) and a new microvascular Doppler US technique (AngioPLUS; SuperSonic Imagine, Aix-en-Provence, France) for differentiating benign and malignant breast masses. Power Doppler US and AngioPLUS findings were available in 124 breast masses with confirmed pathologic results (benign, 80 [64.5%]; malignant, 44 [35.5%]). The diagnostic performance of each tool was calculated to distinguish benign from malignant masses using a receiver operating characteristic curve analysis and compared. The area under the curve showed that AngioPLUS was superior to power Doppler US in differentiating benign from malignant breast masses, but the difference was not statistically significant.
引用
- Jung HK, Park AY, Ko KH, et al. Comparison of the Diagnostic Performance of Power Doppler Ultrasound and a New Microvascular Doppler Ultrasound Technique (AngioPLUS) for Differentiating Benign and Malignant Breast Masses. J Ultrasound Med. 2018. PMID: 29528130. doi:10.1002/jum.14602
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。